Akesobio kicks off virtual roadshow for HK IPO
Akesobio, a Chinese biopharmaceutical firm, has launched an online-only roadshow for its up to HK$2.58bn ($332.9m) IPO amid numerous country-wide lockdowns globally to combat the Covid-19 coronavirus pandemic.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: